Biosafety and selectable markers


Titball, RW; Sjostedt, A; Pavelka, MS; Nano, FE; (2007) Biosafety and selectable markers. In: Abu Kwaik, Y; Metzger, DW; Nano, F; Sjostedt, A; Titball, R, (eds.) Francisella Tularensis: Biology, Pathogenicity, Epidemiology, and Biodefense. Wiley-Blackwell, New York, NY, pp. 405-417. ISBN 978-1-57331-691-0

Full text not available from this repository.

Abstract

Francisella tularensis (F. tularensis) is one of the most infectious pathogens known. Although the disease caused by this bacterium is rarely fatal with appropriate antibiotic therapy, it is often severely debilitating. Laboratory work with F. tularensis poses a significant hazard, and it is essential that appropriate laboratory facilities, trained personnel, and suitable working practices are in place in any organization working with this pathogen. Work with human virulent strains should be carried out at containment level 3. Vaccines play an important potential role in the protection of individuals working with F. tularensis, but the live vaccine strain (LVS) vaccine is not currently licensed for use in humans. Because antibiotic therapy is central to the treatment of human tularemia, antibiotic resistance markers for use in genetic manipulation studies should be carefully selected.

Item Type: Book Section
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology
Web of Science ID: 248298500017
URI: http://researchonline.lshtm.ac.uk/id/eprint/8587

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
263Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item